129 related articles for article (PubMed ID: 1592385)
1. The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis?
Cramer SF; Patel A
Hum Pathol; 1992 Jun; 23(6):635-8. PubMed ID: 1592385
[TBL] [Abstract][Full Text] [Related]
2. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S; Asano R; Wakabayashi R; Hayashi H; Shigeta H
BMC Womens Health; 2022 Aug; 22(1):346. PubMed ID: 35974345
[TBL] [Abstract][Full Text] [Related]
3. Recently discovered interstitial cells "telocytes" as players in the pathogenesis of uterine leiomyomas.
Varga I; Klein M; Urban L; Danihel L; Polak S; Danihel L
Med Hypotheses; 2018 Jan; 110():64-67. PubMed ID: 29317071
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis, cellular proliferation and expression of p53 in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Möller B; Favini R; Lindblom B
Acta Obstet Gynecol Scand; 2000 May; 79(5):397-404. PubMed ID: 10830768
[TBL] [Abstract][Full Text] [Related]
6. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
7. [Uterine leiomyoma: pathogenesis and treatment].
Fujii S
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Aug; 44(8):994-9. PubMed ID: 1402231
[TBL] [Abstract][Full Text] [Related]
8. Significance of postmenopausal uterine leiomyomas: Focus on variants.
Oi Y; Katayama K; Hirata G; Ishidera Y; Yoshida H; Shigeta H
J Obstet Gynaecol Res; 2018 Aug; 44(8):1445-1450. PubMed ID: 29845685
[TBL] [Abstract][Full Text] [Related]
9. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
10. The frequency of uterine leiomyomas.
Cramer SF; Patel A
Am J Clin Pathol; 1990 Oct; 94(4):435-8. PubMed ID: 2220671
[TBL] [Abstract][Full Text] [Related]
11. Mesometrial smooth muscle as an origin of female retroperitoneal (pelvic) leiomyomas.
Watanabe K; Tanaka M; Kusakabe T; Soeda S
Virchows Arch; 2007 Nov; 451(5):899-904. PubMed ID: 17805565
[TBL] [Abstract][Full Text] [Related]
12. Lipomatous neometaplasia of the uterus. Report of 11 cases with discussion of histogenesis and pathogenesis.
Sieiński W
Int J Gynecol Pathol; 1989; 8(4):357-63. PubMed ID: 2807714
[TBL] [Abstract][Full Text] [Related]
13. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids.
Kawaguchi K; Fujii S; Konishi I; Okamura H; Mori T
Gynecol Oncol; 1985 May; 21(1):32-41. PubMed ID: 3886494
[TBL] [Abstract][Full Text] [Related]
15. The relation of fibrous degeneration to menopausal status in small uterine leiomyomas with evidence for postmenopausal origin of seedling myomas.
Cramer SF; Horiszny J; Patel A; Sigrist S
Mod Pathol; 1996 Jul; 9(7):774-80. PubMed ID: 8832561
[TBL] [Abstract][Full Text] [Related]
16. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
Cramer SF; Robertson AL; Ziats NP; Pearson OH
Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
[TBL] [Abstract][Full Text] [Related]
17. Metastasizing leiomyoma of the uterus. S-phase fraction, estrogen receptor, and ultrastructure.
Cramer SF; Meyer JS; Kraner JF; Camel M; Mazur MT; Tenenbaum MS
Cancer; 1980 Mar; 45(5):932-7. PubMed ID: 7260844
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.
Mangrulkar RS; Ono M; Ishikawa M; Takashima S; Klagsbrun M; Nowak RA
Biol Reprod; 1995 Sep; 53(3):636-46. PubMed ID: 7578688
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium.
Kovács KA; Oszter A; Göcze PM; Környei JL; Szabó I
Mol Hum Reprod; 2001 Nov; 7(11):1085-91. PubMed ID: 11675476
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors in uterine leiomyomas.
Marugo M; Centonze M; Bernasconi D; Fazzuoli L; Berta S; Giordano G
Acta Obstet Gynecol Scand; 1989; 68(8):731-5. PubMed ID: 2631544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
